BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 23892008)

  • 1. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC; Crino PB
    Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR signaling in epilepsy: insights from malformations of cortical development.
    Crino PB
    Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal brain malformations: seizures, signaling, sequencing.
    Crino PB
    Epilepsia; 2009 Oct; 50 Suppl 9():3-8. PubMed ID: 19761448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
    Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
    JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATORopathies: The role of amino acid regulatory gene mutations in epilepsy and cortical malformations.
    Iffland PH; Carson V; Bordey A; Crino PB
    Epilepsia; 2019 Nov; 60(11):2163-2173. PubMed ID: 31625153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy.
    Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY
    Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
    Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
    Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
    Wong M
    Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
    Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
    Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
    Jeong A; Wong M
    J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
    Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
    Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal brain malformations: a spectrum of disorders along the mTOR cascade.
    Crino PB
    Novartis Found Symp; 2007; 288():260-72; discussion 272-81. PubMed ID: 18494264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
    Sarnat HB; Flores-Sarnat L
    Brain Dev; 2015 Jun; 37(6):553-62. PubMed ID: 25451314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
    D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
    Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.
    Zhang L; Huang T; Teaw S; Bordey A
    Epilepsia; 2019 Jun; 60(6):1255-1265. PubMed ID: 31125447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
    Gerasimenko A; Baldassari S; Baulac S
    Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of mTOR in maldeveloped balloon cells and dysmorphic neurons of type II focal cortical dysplasia].
    Lin K; Lin YX; Kang DZ; Ye ZX; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):311-5. PubMed ID: 24004587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.